222 related articles for article (PubMed ID: 11972303)
1. A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin.
De Marinis L; Zuppi P; Valle D; Mancini A; Bianchi A; Lauriola L; Pasquini P; Anile C; Maira G; Giustina A
Horm Metab Res; 2002 Mar; 34(3):137-43. PubMed ID: 11972303
[TBL] [Abstract][Full Text] [Related]
2. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
[TBL] [Abstract][Full Text] [Related]
3. The characteristics of acromegalic patients with hyperprolactinemia and the differences in patients with merely GH-secreting adenomas: clinical analysis of 279 cases.
Wang M; Mou C; Jiang M; Han L; Fan S; Huan C; Qu X; Han T; Qu Y; Xu G
Eur J Endocrinol; 2012 May; 166(5):797-802. PubMed ID: 22334636
[TBL] [Abstract][Full Text] [Related]
4. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly.
Biermasz NR; van Dulken H; Roelfsema F
J Clin Endocrinol Metab; 2000 Dec; 85(12):4596-602. PubMed ID: 11134114
[TBL] [Abstract][Full Text] [Related]
5. Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity.
Kaltsas GA; Isidori AM; Florakis D; Trainer PJ; Camacho-Hubner C; Afshar F; Sabin I; Jenkins JP; Chew SL; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2001 Apr; 86(4):1645-52. PubMed ID: 11297598
[TBL] [Abstract][Full Text] [Related]
6. Novel features of tumors that secrete both growth hormone and prolactin in acromegaly.
Nyquist P; Laws ER; Elliott E
Neurosurgery; 1994 Aug; 35(2):179-83; discussion 183-4. PubMed ID: 7969823
[TBL] [Abstract][Full Text] [Related]
7. Octreotide as primary therapy for acromegaly.
Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
[TBL] [Abstract][Full Text] [Related]
8. Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure.
Tindall GT; Oyesiku NM; Watts NB; Clark RV; Christy JH; Adams DA
J Neurosurg; 1993 Feb; 78(2):205-15. PubMed ID: 8421204
[TBL] [Abstract][Full Text] [Related]
9. Factors determining the long-term outcome of surgery for acromegaly.
Osman IA; James RA; Chatterjee S; Mathias D; Kendall-Taylor P
QJM; 1994 Oct; 87(10):617-23. PubMed ID: 7987657
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting the outcome of surgical treatment of acromegaly.
Er LK; Chang TC; Lin SM; Huang KM; Chang CC
J Formos Med Assoc; 2000 Mar; 99(3):191-8. PubMed ID: 10820950
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
[TBL] [Abstract][Full Text] [Related]
13. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
[TBL] [Abstract][Full Text] [Related]
14. The characteristics of acromegalic patients with hyperprolactinemia and the differences with hyperprolactinemia patients.
Huan C; Cui G; Ren Z
Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):713-8. PubMed ID: 25796163
[TBL] [Abstract][Full Text] [Related]
15. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.
Kreutzer J; Vance ML; Lopes MB; Laws ER
J Clin Endocrinol Metab; 2001 Sep; 86(9):4072-7. PubMed ID: 11549628
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.
Hazer DB; Işık S; Berker D; Güler S; Gürlek A; Yücel T; Berker M
J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496
[TBL] [Abstract][Full Text] [Related]
17. Transsphenoidal surgery in acromegaly investigated by intraoperative high-field magnetic resonance imaging.
Fahlbusch R; Keller Bv; Ganslandt O; Kreutzer J; Nimsky C
Eur J Endocrinol; 2005 Aug; 153(2):239-48. PubMed ID: 16061830
[TBL] [Abstract][Full Text] [Related]
18. Reliability of the oral glucose tolerance test in the early postoperative assessment of acromegaly remission.
Kristof RA; Neuloh G; Redel L; Klingmüller D; Schramm J
J Neurosurg; 2002 Dec; 97(6):1282-6. PubMed ID: 12507124
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of glycoprotein hormone alpha subunit in somatoprolactinic and pure somatotroph adenomas.
Vantyghem MC; Cortet C; Bauters C; Gevaert MH; Dewailly D; Lefebvre J; Mazzucca M
J Endocrinol Invest; 1998; 21(7):434-40. PubMed ID: 9766257
[TBL] [Abstract][Full Text] [Related]
20. Circulating non-22-kilodalton growth hormone isoforms in acromegalic men before and after transsphenoidal surgery.
Boguszewski CL; Johannsson G; Bengtsson BA; Johansson A; Carlsson B; Carlsson LM
J Clin Endocrinol Metab; 1997 May; 82(5):1516-21. PubMed ID: 9141543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]